170 related articles for article (PubMed ID: 24178904)
21. JMJD2A predicts prognosis and regulates cell growth in human gastric cancer.
Hu CE; Liu YC; Zhang HD; Huang GJ
Biochem Biophys Res Commun; 2014 Jun; 449(1):1-7. PubMed ID: 24802408
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab.
Nishida N; Mimori K; Fabbri M; Yokobori T; Sudo T; Tanaka F; Shibata K; Ishii H; Doki Y; Mori M
Clin Cancer Res; 2011 May; 17(9):2725-33. PubMed ID: 21220473
[TBL] [Abstract][Full Text] [Related]
23. TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells.
Howlin J; Rosenkvist J; Andersson T
Breast Cancer Res; 2008; 10(2):R36. PubMed ID: 18435854
[TBL] [Abstract][Full Text] [Related]
24. Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer.
Li P; Qian J; Yu G; Chen Y; Liu K; Li J; Wang J
J Surg Oncol; 2012 Jan; 105(1):31-7. PubMed ID: 22161898
[TBL] [Abstract][Full Text] [Related]
25. Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma.
Kanaji S; Saito H; Tsujitani S; Matsumoto S; Tatebe S; Kondo A; Ozaki M; Ito H; Ikeguchi M
Oncology; 2006; 70(2):126-33. PubMed ID: 16645325
[TBL] [Abstract][Full Text] [Related]
26. HER2 status in unusual histological variants of gastric adenocarcinomas.
Giuffrè G; Ieni A; Barresi V; Caruso RA; Tuccari G
J Clin Pathol; 2012 Mar; 65(3):237-41. PubMed ID: 22067088
[TBL] [Abstract][Full Text] [Related]
27. Amplification of c-erbB2 oncogene: a major prognostic indicator in uterine serous papillary carcinoma.
Santin AD; Bellone S; Van Stedum S; Bushen W; Palmieri M; Siegel ER; De Las Casas LE; Roman JJ; Burnett A; Pecorelli S
Cancer; 2005 Oct; 104(7):1391-7. PubMed ID: 16116605
[TBL] [Abstract][Full Text] [Related]
28. EGFR gene copy number increase in vulvar carcinomas is linked with poor clinical outcome.
Woelber L; Hess S; Bohlken H; Tennstedt P; Eulenburg C; Simon R; Gieseking F; Jaenicke F; Mahner S; Choschzick M
J Clin Pathol; 2012 Feb; 65(2):133-9. PubMed ID: 22128196
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Fibroblast Growth Factor Receptor 2 Expression, Heterogeneity and Clinical Significance in Gastric Cancer.
Han N; Kim MA; Lee HS; Kim WH
Pathobiology; 2015; 82(6):269-79. PubMed ID: 26516773
[TBL] [Abstract][Full Text] [Related]
30. The Prognostic Significance of c-MET and EGFR Overexpression in Resected Gastric Adenocarcinomas.
Paliga A; Marginean H; Tessier-Cloutier B; Purgina B; Jonker D; Marginean EC
Am J Clin Oncol; 2017 Dec; 40(6):543-551. PubMed ID: 26125303
[TBL] [Abstract][Full Text] [Related]
31. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
Yu J; Cheng YY; Tao Q; Cheung KF; Lam CN; Geng H; Tian LW; Wong YP; Tong JH; Ying JM; Jin H; To KF; Chan FK; Sung JJ
Gastroenterology; 2009 Feb; 136(2):640-51.e1. PubMed ID: 19084528
[TBL] [Abstract][Full Text] [Related]
32. Constitutive activation of signal transducers and activators of transcription 3 correlates with better prognosis, cell proliferation and hypoxia-inducible factor-1α in human gastric cancer.
Woo S; Lee BL; Yoon J; Cho SJ; Baik TK; Chang MS; Lee HE; Park JW; Kim YH; Kim WH
Pathobiology; 2011; 78(6):295-301. PubMed ID: 22104200
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of SPARC gene expression in patients with gastric cancer.
Sato T; Oshima T; Yamamoto N; Yamada T; Hasegawa S; Yukawa N; Numata K; Kunisaki C; Tanaka K; Shiozawa M; Yoshikawa T; Akaike M; Rino Y; Imada T; Masuda M
J Surg Oncol; 2013 Nov; 108(6):364-8. PubMed ID: 24018911
[TBL] [Abstract][Full Text] [Related]
34. WD40 repeat-containing 62 overexpression as a novel indicator of poor prognosis for human gastric cancer.
Zeng S; Tao Y; Huang J; Zhang S; Shen L; Yang H; Pei H; Zhong M; Zhang G; Liu T; Zhou M; Shen H
Eur J Cancer; 2013 Nov; 49(17):3752-62. PubMed ID: 23920402
[TBL] [Abstract][Full Text] [Related]
35. Chromogenic in situ hybridization (CISH) to detect HER2 gene amplification in breast and gastric cancer: comparison with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH).
Kiyose S; Igarashi H; Nagura K; Kamo T; Kawane K; Mori H; Ozawa T; Maeda M; Konno K; Hoshino H; Konno H; Ogura H; Shinmura K; Hattori N; Sugimura H
Pathol Int; 2012 Nov; 62(11):728-34. PubMed ID: 23121603
[TBL] [Abstract][Full Text] [Related]
36. Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancer.
Hou Q; Wu YH; Grabsch H; Zhu Y; Leong SH; Ganesan K; Cross D; Tan LK; Tao J; Gopalakrishnan V; Tang BL; Kon OL; Tan P
Cancer Res; 2008 Jun; 68(12):4623-30. PubMed ID: 18559507
[TBL] [Abstract][Full Text] [Related]
37. Mitogen-activated protein kinase activator with WD40 repeats (MAWD) and MAWD-binding protein induce cell differentiation in gastric cancer.
Li D; Zhang J; Xi Y; Zhang L; Li W; Cui J; Xing R; Pan Y; Pan Z; Li F; Lu Y
BMC Cancer; 2015 Sep; 15():637. PubMed ID: 26373288
[TBL] [Abstract][Full Text] [Related]
38. Gene copy number gain of EGFR is a poor prognostic biomarker in gastric cancer: evaluation of 855 patients with bright-field dual in situ hybridization (DISH) method.
Higaki E; Kuwata T; Nagatsuma AK; Nishida Y; Kinoshita T; Aizawa M; Nitta H; Nagino M; Ochiai A
Gastric Cancer; 2016 Jan; 19(1):63-73. PubMed ID: 25487305
[TBL] [Abstract][Full Text] [Related]
39. Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer.
Wu Y; Yun D; Zhao Y; Wang Y; Sun R; Yan Q; Zhang S; Lu M; Zhang Z; Lu D; Li Y
Oncotarget; 2017 Jan; 8(1):1262-1277. PubMed ID: 27902480
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of GNAO1 correlates with poor prognosis in patients with gastric cancer and plays a role in gastric cancer cell proliferation and apoptosis.
Liu Z; Zhang J; Wu L; Liu J; Zhang M
Int J Mol Med; 2014 Mar; 33(3):589-96. PubMed ID: 24366063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
